Ingredient or product comparison
Quickcomparison
Dose Range Copper Tripeptide-1 (GHK-Cu) 0.01%–1% % GHK-Cu 1–3 mg Frequency Once daily Administration Topical Subcutaneous injection Cycle Length Ongoing/indefinite 8-12 weeks Onset Speed Moderate (1-2 weeks) Evidence Level Limited human trials Strong preclinic
This source-based comparison does not add ratings or recommend a winner.
- Dose Range
- Copper Tripeptide-1 (GHK-Cu)
- 0.01%–1% %
- GHK-Cu
- 1–3 mg
- Frequency
- Once daily
- Administration
- Topical
- Subcutaneous injection
- Cycle Length
- Ongoing/indefinite
- 8-12 weeks
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Limited human trials
- Strong preclinical (extensive animal studies)
- Efficacy